PHARMAZIE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812032, encodeId=005b812032e2, content=投了一篇中药物质基础的文章，12天后悲剧了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/308143e428c14d0590e9026a1718e0db/9f2eb4c6f2004e4faa879f62538c22b6.jpg, createdBy=56f45379989, createdName=ms8000001980435671, createdTime=Sat Aug 22 14:41:00 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924919, encodeId=3d329249194c, content=想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/c6ca6dee526f1b3d5a40cd32a1d98745.jpg, createdBy=efa62507320, createdName=kirsten, createdTime=Tue Feb 16 17:03:51 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576364, encodeId=b2495e6364a8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dcc2423101, createdName=1239e0cfm09(暂无昵称), createdTime=Sun Sep 15 20:44:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528912, encodeId=e11d528912c4, content=我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀! 中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Nov 02 19:51:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-05-21 榴莲味少女

最近有没有接收的朋友。。我投稿一个月了一点消息都没有

190 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812032, encodeId=005b812032e2, content=投了一篇中药物质基础的文章，12天后悲剧了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/308143e428c14d0590e9026a1718e0db/9f2eb4c6f2004e4faa879f62538c22b6.jpg, createdBy=56f45379989, createdName=ms8000001980435671, createdTime=Sat Aug 22 14:41:00 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924919, encodeId=3d329249194c, content=想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/c6ca6dee526f1b3d5a40cd32a1d98745.jpg, createdBy=efa62507320, createdName=kirsten, createdTime=Tue Feb 16 17:03:51 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576364, encodeId=b2495e6364a8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dcc2423101, createdName=1239e0cfm09(暂无昵称), createdTime=Sun Sep 15 20:44:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528912, encodeId=e11d528912c4, content=我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀! 中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Nov 02 19:51:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-01 emmawang

偏重的研究方向：临床研究
经验分享：投稿8天，在等待中

103 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812032, encodeId=005b812032e2, content=投了一篇中药物质基础的文章，12天后悲剧了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/308143e428c14d0590e9026a1718e0db/9f2eb4c6f2004e4faa879f62538c22b6.jpg, createdBy=56f45379989, createdName=ms8000001980435671, createdTime=Sat Aug 22 14:41:00 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924919, encodeId=3d329249194c, content=想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/c6ca6dee526f1b3d5a40cd32a1d98745.jpg, createdBy=efa62507320, createdName=kirsten, createdTime=Tue Feb 16 17:03:51 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576364, encodeId=b2495e6364a8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dcc2423101, createdName=1239e0cfm09(暂无昵称), createdTime=Sun Sep 15 20:44:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528912, encodeId=e11d528912c4, content=我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀! 中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Nov 02 19:51:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-01-04 药剂学萌新

被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭

63 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812032, encodeId=005b812032e2, content=投了一篇中药物质基础的文章，12天后悲剧了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/308143e428c14d0590e9026a1718e0db/9f2eb4c6f2004e4faa879f62538c22b6.jpg, createdBy=56f45379989, createdName=ms8000001980435671, createdTime=Sat Aug 22 14:41:00 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924919, encodeId=3d329249194c, content=想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/c6ca6dee526f1b3d5a40cd32a1d98745.jpg, createdBy=efa62507320, createdName=kirsten, createdTime=Tue Feb 16 17:03:51 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576364, encodeId=b2495e6364a8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dcc2423101, createdName=1239e0cfm09(暂无昵称), createdTime=Sun Sep 15 20:44:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528912, encodeId=e11d528912c4, content=我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀! 中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Nov 02 19:51:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 药剂学萌新

偏重的研究方向：药动学
经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊

84 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812032, encodeId=005b812032e2, content=投了一篇中药物质基础的文章，12天后悲剧了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/308143e428c14d0590e9026a1718e0db/9f2eb4c6f2004e4faa879f62538c22b6.jpg, createdBy=56f45379989, createdName=ms8000001980435671, createdTime=Sat Aug 22 14:41:00 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924919, encodeId=3d329249194c, content=想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/c6ca6dee526f1b3d5a40cd32a1d98745.jpg, createdBy=efa62507320, createdName=kirsten, createdTime=Tue Feb 16 17:03:51 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576364, encodeId=b2495e6364a8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dcc2423101, createdName=1239e0cfm09(暂无昵称), createdTime=Sun Sep 15 20:44:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528912, encodeId=e11d528912c4, content=我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀! 中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Nov 02 19:51:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-08-22 ms8000001980435671

投了一篇中药物质基础的文章，12天后悲剧了！

115 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812032, encodeId=005b812032e2, content=投了一篇中药物质基础的文章，12天后悲剧了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/308143e428c14d0590e9026a1718e0db/9f2eb4c6f2004e4faa879f62538c22b6.jpg, createdBy=56f45379989, createdName=ms8000001980435671, createdTime=Sat Aug 22 14:41:00 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924919, encodeId=3d329249194c, content=想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/c6ca6dee526f1b3d5a40cd32a1d98745.jpg, createdBy=efa62507320, createdName=kirsten, createdTime=Tue Feb 16 17:03:51 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576364, encodeId=b2495e6364a8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dcc2423101, createdName=1239e0cfm09(暂无昵称), createdTime=Sun Sep 15 20:44:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528912, encodeId=e11d528912c4, content=我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀! 中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Nov 02 19:51:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-02-16 kirsten

想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。

80 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812032, encodeId=005b812032e2, content=投了一篇中药物质基础的文章，12天后悲剧了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/308143e428c14d0590e9026a1718e0db/9f2eb4c6f2004e4faa879f62538c22b6.jpg, createdBy=56f45379989, createdName=ms8000001980435671, createdTime=Sat Aug 22 14:41:00 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924919, encodeId=3d329249194c, content=想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/c6ca6dee526f1b3d5a40cd32a1d98745.jpg, createdBy=efa62507320, createdName=kirsten, createdTime=Tue Feb 16 17:03:51 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576364, encodeId=b2495e6364a8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dcc2423101, createdName=1239e0cfm09(暂无昵称), createdTime=Sun Sep 15 20:44:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528912, encodeId=e11d528912c4, content=我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀! 中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Nov 02 19:51:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2019-09-15 1239e0cfm09(暂无昵称)

审稿速度:1.0 | 投稿命中率:75.0
经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。

144 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812032, encodeId=005b812032e2, content=投了一篇中药物质基础的文章，12天后悲剧了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/308143e428c14d0590e9026a1718e0db/9f2eb4c6f2004e4faa879f62538c22b6.jpg, createdBy=56f45379989, createdName=ms8000001980435671, createdTime=Sat Aug 22 14:41:00 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924919, encodeId=3d329249194c, content=想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/c6ca6dee526f1b3d5a40cd32a1d98745.jpg, createdBy=efa62507320, createdName=kirsten, createdTime=Tue Feb 16 17:03:51 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576364, encodeId=b2495e6364a8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dcc2423101, createdName=1239e0cfm09(暂无昵称), createdTime=Sun Sep 15 20:44:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528912, encodeId=e11d528912c4, content=我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀! 中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Nov 02 19:51:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2016-11-02 da-xiang

我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀!

中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。

320 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812032, encodeId=005b812032e2, content=投了一篇中药物质基础的文章，12天后悲剧了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/308143e428c14d0590e9026a1718e0db/9f2eb4c6f2004e4faa879f62538c22b6.jpg, createdBy=56f45379989, createdName=ms8000001980435671, createdTime=Sat Aug 22 14:41:00 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924919, encodeId=3d329249194c, content=想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/c6ca6dee526f1b3d5a40cd32a1d98745.jpg, createdBy=efa62507320, createdName=kirsten, createdTime=Tue Feb 16 17:03:51 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576364, encodeId=b2495e6364a8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dcc2423101, createdName=1239e0cfm09(暂无昵称), createdTime=Sun Sep 15 20:44:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528912, encodeId=e11d528912c4, content=我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀! 中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Nov 02 19:51:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-27 rayms

评审和期刊编辑要求我补实验，就一定要补么，不补行不行？

64 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812032, encodeId=005b812032e2, content=投了一篇中药物质基础的文章，12天后悲剧了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/308143e428c14d0590e9026a1718e0db/9f2eb4c6f2004e4faa879f62538c22b6.jpg, createdBy=56f45379989, createdName=ms8000001980435671, createdTime=Sat Aug 22 14:41:00 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924919, encodeId=3d329249194c, content=想问一下这个杂志是没有with editor的过程吗，直接就under review了。还是说这个under review里把编辑审稿和外审都包括进去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/c6ca6dee526f1b3d5a40cd32a1d98745.jpg, createdBy=efa62507320, createdName=kirsten, createdTime=Tue Feb 16 17:03:51 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576364, encodeId=b2495e6364a8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：8月11号投的文章，9月10号杂志社直接决定接收文章。个人认为，杂志的要求不高。但是一定要按照杂志社的要求上传手稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dcc2423101, createdName=1239e0cfm09(暂无昵称), createdTime=Sun Sep 15 20:44:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528912, encodeId=e11d528912c4, content=我也注册了一个，第一次也像你说的，根本没收到邮件。我又重新注册了一个，后面终于到了。感觉要看运气啊~话说这个杂志是哪个国家的呀! 中药也收的，我看了有混合物的药理研究~我也正打算投篇中药的试试。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Nov 02 19:51:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

对于审稿人好的意见也要回复么？

72 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务